Short answer · Medically reviewed summary · Last updated: 2026-04-07
Parkinson's disease was first formally described in 1817 by English apothecary James Parkinson, who published his landmark medical essay, An Essay on the Shaking Palsy, detailing the clinical characteristics of the condition. From "Shaking Palsy" to Clinical Understanding James Parkinson initially identified six individuals exhibiting what he termed "shaking palsy," noting symptoms such as resting tremors, postural instability, and a forward-leaning gait. It was not until decades later that the French neurologist Jean-Martin Charcot refined these observations, distinguishing the condition from other movement disorders and formally proposing that the disease be named in honor of James Parkinson.
1 people with Parkinson have shared their first-person experience on this question at DiseaseMaps.
What is the history of Parkinson?
History of Parkinson: when and how it was discovered, and the milestones in research since, medically reviewed.
Parkinson's disease was first formally described in 1817 by English apothecary James Parkinson, who published his landmark medical essay, An Essay on the Shaking Palsy, detailing the clinical characteristics of the condition.
From "Shaking Palsy" to Clinical Understanding
James Parkinson initially identified six individuals exhibiting what he termed "shaking palsy," noting symptoms such as resting tremors, postural instability, and a forward-leaning gait. It was not until decades later that the French neurologist Jean-Martin Charcot refined these observations, distinguishing the condition from other movement disorders and formally proposing that the disease be named in honor of James Parkinson. Throughout the late 19th and early 20th centuries, medical understanding shifted from viewing Parkinson as a purely mechanical issue to recognizing it as a progressive neurodegenerative disorder primarily affecting the basal ganglia.
Milestones in Treatment and Genetics
The most transformative moment in the history of Parkinson occurred in the 1960s with the discovery of dopamine deficiency in the brain, which led to the development of Levodopa. This therapy revolutionized the management of Parkinson, offering many patients a significant improvement in quality of life. In the modern era, the integration of genetics has further refined our perspective; researchers have identified specific gene mutations, such as SNCA and LRRK2, which have shifted our understanding of Parkinson from a singular clinical entity to a spectrum of underlying biological processes. Furthermore, the advent of Deep Brain Stimulation (DBS) has provided a surgical milestone for those who no longer respond adequately to pharmacological interventions.
Advocacy and Awareness
Historically, patients often faced social stigma due to misconceptions regarding the tremors and speech impairments associated with Parkinson. Over the last century, patient advocacy groups have been instrumental in destigmatizing the condition. Today, global communities like those found on DiseaseMaps empower individuals to share their lived experiences, fostering a sense of solidarity and accelerating the push for better research funding and more personalized care models.
Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or other qualified health provider with any questions regarding your medical condition.
References
- National Institute of Neurological Disorders and Stroke (NINDS) - Parkinson’s Disease Information Page
- NIH Genetic and Rare Diseases Information Center (GARD)
- The Michael J. Fox Foundation for Parkinson's Research
- Orphanet: Parkinson disease
Posted Nov 18, 2019 by Angie P. 5000
